Montana

PRESS RELEASES

Business

FYR Diagnostics Welcomes Dr. Kirk Tanner and Dr. Andy Hill to its Scientific Advisory Board

November 28, 2023

·

3 min read

BioForest

Alercell’s Latest Intellectual Property In-License Bolsters Leukemia Diagnostic Test Advancements

October 25, 2023

·

2 min read

BioForest

Inimmune Collaborates with Boston Children’S Hospital to Develop Novel Adjuvants

October 24, 2023

·

3 min read

BioForest

Microbion CEO to Participate in Panel Discussion at BioFuture 2023

October 5, 2023

·

4 min read

Inimmune CSO Jay Evans to present an update on clinical stage programs at the International Precision Vaccine Conference in Rome, Italy on October 5-6

September 28, 2023

·

2 min read

BioForest

Golden Helix Receives New NIH SBIR Grant

September 26, 2023

·

1 min read

INIMMUNE TO PRESENT ON NOVEL ADJUVANTS AT THE 17TH VACCINE CONGRESS ON SEPTEMBER 26TH, 2023

September 21, 2023

·

3 min read

Business

FYR DIAGNOSTICS WELCOMES DR. NIALL LENNON AND DR. RYAN WALTERS TO ITS SCIENTIFIC ADVISORY BOARD

August 23, 2023

·

3 min read

Microbion Presented New Pravibismane Data Against Mycobacteroides abscessus at the 6th World Bronchiectasis and NTM Conference

August 15, 2023

·

4 min read

Drug Development

Microbion to Present Design of Ongoing Phase 2 Study Treating Diabetic Foot Ulcer Infections at the 2023 Military Health System Research Symposium

August 14, 2023

·

5 min read

Drug Development

Inimmune Corporation announces First Subject Dosed in First-in-Human Phase 1 Clinical Trial of its novel intranasal TLR4 agonist, INI-2004, for the Treatment of Allergic Rhinitis and FDA Clearance of IND application for INI-2004

August 2, 2023

·

3 min read